Skip to main content
Equibles

Jessie Yeung

Head of Investor Relations

Legend Biotech Corp (LEGN)

Equibles does not estimate personal net worth.

Get an email with a short summary when Legend Biotech Corp publishes a filing, an earnings call transcript or a press release.

Get LEGN alerts

About Jessie Yeung

Jessie Yeung is recorded as Head of Investor Relations at Legend Biotech Corp (LEGN). Jessie Yeung has spoken on 10 earnings calls across 1 company, most recently for Legend Biotech Corp on September 30, 2025. Legend Biotech Corp is classified in the Biotechnology industry within the Healthcare sector.

Jessie Yeung on recent calls

“Thank you for joining our conference call today to review our third quarter of 2025 performance. Prior to this call, we issued a press release announcing our financing results for the quarter.”
Head of Investor Relations, Legend Biotech Corp Q3 FY2025 Earnings Call ·
“During the second quarter, we delivered solid financial results with CARVYKTI net sales up 136% year-over-year. Total revenues were $255 million, driven by collaboration revenue growth of 136% year-over-year.”
CFO, Legend Biotech Corp Q2 FY2025 Earnings Call ·
“During the first quarter we delivered solid financial results with CARVYKTI net sales up 135% year-over-year. Total revenues were $195 million, driven by collaboration revenue growth of 137% year-over-year.”
CFO, Legend Biotech Corp Q1 FY2025 Earnings Call ·
“As Ying mentioned, we generated approximately $334 million in total net sales for CARVYKTI during the fourth quarter, an increase of 110% year-over-year. As a reminder, we share equally in all profits and losses of CARVYKTI with our partner, Janssen.”
CFO, Legend Biotech Corp Q4 FY2024 Earnings Call ·
“Joining me on today's call are Ying Huang, the company's Chief Executive Officer; and Lori Macomber, the company's Chief Financial Officer.”
Head of Investor Relations, Legend Biotech Corp Q3 FY2024 Earnings Call ·

Affiliation history

Company network

Recent activity